PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP InhibitionYasir H. Ibrahim, José Baselga, Pilar Antón et al.|Cancer Discovery|2012Cited by 622
Biomimetic Dendritic Cell-Based Nanovaccines for Reprogramming the Immune Microenvironment to Boost Tumor ImmunotherapyWeizhong Wang, Jintao Gu, Cheng Zou et al.|ACS Nano|2024Cited by 26
Targeting GDF15 to enhance immunotherapy efficacy in glioblastoma through tumor microenvironment-responsive CRISPR-Cas9 nanoparticlesCheng Zou, Meng Li, Xiao Liu et al.|Journal of Nanobiotechnology|2025Cited by 15